Mdxhealth Announces Peer-Reviewed Publication of Oxford GPS-ProMPT Study in European Urology Oncology, Establishing Scientific Foundation for the Landmark GPS-ProtecT Randomized Controlled Trial
Mdxhealth SA announced the peer-reviewed publication of the Oxford GPS-ProMPT study in European Urology Oncology, establishing significant scientific validation for its GPS mdx genomic prostate cancer test. This study's findings underpin the ongoing GPS-ProtecT randomized controlled trial, aimed at proving GPS mdx as the first genomic classifier va…